Investor Relations Home

Profile
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market.

The Company was incorporated in California in February 1989 as IRIS Medical Instruments, Inc. In November 1995, we changed our name to IRIDEX Corporation and reincorporated in Delaware. Investors and others should note that we announce material financial information to our investors using SEC filings, press releases, our investor relations website, public conference calls and webcasts.  We use these channels as well as social media to communicate with investors, customers and the public about our company, our products and other issues.  It is possible that the information we post on social media channels could be deemed to be material information.  We encourage investors, our customers, and others interested in our company to review the information we post on our Facebook page (www.facebook.com/IRIDEX) and Twitter feed (https://twitter.com/IRIDEX).
Stock Quote
IRIX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$7.79
Change (%) Stock is Down 0.08 (1.02%)
Volume22,948
Data as of 09/18/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
08/27/14IRIDEX to Present at Robert W. Baird 2014 Health Care Conference
MOUNTAIN VIEW, Calif., Aug. 27, 2014 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that COO and CFO James H. Mackaness is scheduled to make an investor presentation at the Robert W. Baird 2014 Health Care Conference at 2:55 p.m. Eastern Time on Wednesday, September 3, in New York City.  A live audio webcast of the investor presentation will be available in the Investors section of the IRIDEX website at http://www.iridex.com/. About IRIDEX IRIDEX Corporation was fou... 
Printer Friendly Version
08/07/14Director Garrett A. Garrettson, Ph.D. to Step Down After Decade-Long Service
MOUNTAIN VIEW, Calif., Aug. 7, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that, after more than a decade of service, Garrett A. Garrettson has resigned his seat on the IRIDEX Board of Directors. President and CEO Will Moore said, "Garry's insight and guidance on matters of technology, capital markets and corporate governance were a constant and steadying force through some very eventful years at IRIDEX. On behalf of all the shareholders, we are grateful for his dec... 
Printer Friendly Version
08/05/14IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference
MOUNTAIN VIEW, Calif., Aug. 5, 2014 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that President and CEO Will Moore is scheduled to make an investor presentation at the 2014 Wedbush Life Sciences Management Access Conference at 1:55 p.m. Eastern Time on Tuesday, August 12, in New York City. In addition, Mr. Moore will participate on a panel at the conference discussing Ophthalmology Treatments & Tools at 11:30 a.m. Eastern Time on Tuesday, August 12th. A live audio web... 
Printer Friendly Version
07/31/14IRIDEX Reports 2014 Second Quarter, Six-Month Results
Revenue Up 15% Year over Year for Both Periods Board of Directors Establishes New Share Repurchase Program MOUNTAIN VIEW, Calif., July 31, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended June 28, 2014.  Revenues were $10.6 million in the second quarter of 2014, up 15% from $9.2 million in the 2013 second quarter and up sequentially from $10.3 million in the first quarter of 2014. Revenues for the firs... 
Printer Friendly Version
Primary IR Contact
Jim Mackaness
Chief Financial Officer and Chief Operating Officer
Phone: 650-605-8716
E-mail: jmackaness@iridex.com


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina